Literature DB >> 9551718

Necessity of interleukin-1beta converting enzyme cascade in taxotere-initiated death signaling.

A Suzuki1, T Kawabata, M Kato.   

Abstract

Taxotere is a new type chemotherapeutic agent which targets tubulin. In the present study, we investigated the molecular machinery of taxotere-initiated death signaling. Taxotere induced cell death in mouse fibroblast L929 cells. Cell morphological analysis revealed that this effect showed characteristics of apoptotic and necrotic cell death. To further examine taxotere-induced cell death, we investigated the direct involvement of caspase. When cells were pretreated with the synthesized tetrapeptide inhibitor of caspase, YVAD-CHO (Ac-Tyr-Val-Ala-Asp-aldehyde: inhibitor of interleukin-1beta converting enzyme (ICE) subfamily) or DEVD-CHO (Ac-Asp-Glu-Val-Asp-aldehyde: inhibitor of CPP32 subfamily), taxotere-induced cell death was prevented. In addition, time course experiments demonstrated that activation of the ICE subfamily preceded activation of the CPP32 subfamily in taxotere-initiated death signaling, suggesting the direct involvement of the ICE cascade in taxotere-initiated death signaling. On the basis of these results, we suggest that taxotere causes the initiation of ICE cascade in its death signaling pathway and that the down-stream site of taxotere-initiated death signaling is the same as that of other chemotherapeutic agents.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9551718     DOI: 10.1016/s0014-2999(97)01520-3

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  8 in total

1.  Mitochondrial regulation of cell death: mitochondria are essential for procaspase 3-p21 complex formation to resist Fas-mediated cell death.

Authors:  A Suzuki; Y Tsutomi; N Yamamoto; T Shibutani; K Akahane
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

Review 2.  Docetaxel: a review of its use in non-small cell lung cancer.

Authors:  A M Comer; K L Goa
Journal:  Drugs Aging       Date:  2000-07       Impact factor: 3.923

3.  GDP dissociation inhibitor D4-GDI (Rho-GDI 2), but not the homologous rho-GDI 1, is cleaved by caspase-3 during drug-induced apoptosis.

Authors:  F Essmann; T Wieder; A Otto; E C Müller; B Dörken; P T Daniel
Journal:  Biochem J       Date:  2000-03-15       Impact factor: 3.857

4.  Identification of a novel synthetic thiazolidin compound capable of inducing c-Jun NH2-terminal kinase-dependent apoptosis in human colon cancer cells.

Authors:  Fuminori Teraishi; Shuhong Wu; Lidong Zhang; Wei Guo; John J Davis; Fengqin Dong; Bingliang Fang
Journal:  Cancer Res       Date:  2005-07-15       Impact factor: 12.701

5.  Inhibitory activity of nuclear factor-kappaB potentiates cisplatin-induced apoptosis in A549 cells.

Authors:  Jian Zhang; Yongjian Xu; Weining Xiong; Zhenxiang Zhang; Chunling Du; Lifen Qiao; Wang Ni; Shixin Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-06-19

6.  Expression of procaspase 3 and activated caspase 3 and its relevance in hormone-responsive gallbladder carcinoma chemotherapy.

Authors:  Sanjeev Kumar Maurya; Mallika Tewari; Bechan Sharma; Hari Shanker Shukla
Journal:  Korean J Intern Med       Date:  2013-08-14       Impact factor: 2.884

7.  A review on the effects of current chemotherapy drugs and natural agents in treating non-small cell lung cancer.

Authors:  Chih-Yang Huang; Da-Tong Ju; Chih-Fen Chang; P Muralidhar Reddy; Bharath Kumar Velmurugan
Journal:  Biomedicine (Taipei)       Date:  2017-11-13

8.  Combining inhibition of galectin-3 with and before a therapeutic vaccination is critical for the prostate-tumor-free outcome.

Authors:  Carolina Tiraboschi; Lucas Gentilini; Carla Velazquez; Enrique Corapi; Felipe Martín Jaworski; José Daniel Garcia Garcia; Yorfer Rondón; Anne Chauchereau; Diego José Laderach; Daniel Compagno
Journal:  J Immunother Cancer       Date:  2020-12       Impact factor: 13.751

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.